The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US9096596, 58 ID: ALA3674077
Chembl Id: CHEMBL3674077
PubChem CID: 86282366
Max Phase: Preclinical
Molecular Formula: C20H17ClF3N5O
Molecular Weight: 435.84
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1nc2c(c(-c3ccn[nH]3)n1)C[C@@H](C)N(C(=O)c1cccc(C(F)(F)F)c1Cl)C2
Standard InChI: InChI=1S/C20H17ClF3N5O/c1-10-8-13-16(26-11(2)27-18(13)15-6-7-25-28-15)9-29(10)19(30)12-4-3-5-14(17(12)21)20(22,23)24/h3-7,10H,8-9H2,1-2H3,(H,25,28)/t10-/m1/s1
Standard InChI Key: IKDSIXDWHJJKMA-SNVBAGLBSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 435.84Molecular Weight (Monoisotopic): 435.1074AlogP: 4.43#Rotatable Bonds: 2Polar Surface Area: 74.77Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.06CX Basic pKa: 2.27CX LogP: 3.80CX LogD: 3.79Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.65Np Likeness Score: -1.35
References 1. (2015) P2X7 modulators, 2. Rech JC, Bhattacharya A, Letavic MA, Savall BM.. (2016) The evolution of P2X7 antagonists with a focus on CNS indications., 26 (16): [PMID:27426304 ] [10.1016/j.bmcl.2016.06.048 ]